Lerozot 2.5 Tablet
Marketer
Care Formulation Labs Pvt Ltd
Salt Composition
Letrozole (2.5mg)
Overview Lerozot 2.5 Tablet
Postmenopausal women with breast cancer may find relief with Lerozot 2.5mg tablets. This medication can be administered independently or in conjunction with other therapies like surgery or radiotherapy. In advanced breast cancer, it aids in hindering metastasis. Lerozot 2.5mg tablets can be ingested with or without food, always adhering to your physician's prescribed dosage and duration for optimal efficacy. Dosage frequency is tailored to individual needs and determined by your doctor based on your specific condition. Continuous use, as directed, is crucial. Commonly reported side effects encompass hot flushes, tiredness, increased perspiration, and elevated cholesterol. Report any concerning or persistent side effects to your doctor; management strategies are available. Prior to commencing treatment, disclose any history of liver or kidney impairment, or osteoporosis. Comprehensive medication disclosure is essential, as drug interactions can impact Lerozot's effectiveness. Inform your doctor if you are pregnant or nursing. Pre- and ongoing treatment blood tests to monitor vitamin D levels and bone density may be conducted.
Uses of Lerozot 2.5 Tablet
Managing Breast Cancer
Major Benefits of Lerozot 2.5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Lerozot 2.5mg tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Lerozot 2.5 Tablet:
- Dizziness
- Fatigue
- Weakness
- Bone pain
- Back pain
- Night sweats
- Joint pain
- Nausea
- Osteoporosis
- Joint inflammation
- Weight gain
- Hot flushes
- Edema (swelling)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Diaphoresis
- Bone fracture
- Hypercholesterolemia (high cholesterol)
- Cough
- Shortness of breath
How to use Lerozot 2.5 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Lerozot 2.5mg tablets can be consumed with or without food, although consistent timing is recommended.
How Lerozot 2.5 Tablet works:
Lerozot 2.5mg tablets function as an aromatase inhibitor, reducing the body's estrogen production. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Lerozot 2.5 Tablet and alcohol consumption.
PregnancyUNSAFE
Using Lerozot 2.5 Tablet during pregnancy poses a substantial risk. Pregnant women should consult their physician; research in both animals and pregnant humans indicates significant harm to the fetus.
Breast feedingUNSAFE
Use of Lerozot 2.5 Tablet is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Taking Lerozot 2.5 Tablet may cause drowsiness, blurred vision, and dizziness, reducing alertness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Lerozot 2.5 mg tablets are considered safe for patients with kidney impairment; no dosage modification is typically necessary. Nevertheless, data regarding its use in individuals with terminal kidney disease is scarce. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should use Lerozot 2.5mg tablets cautiously. Dosage modification of Lerozot 2.5mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Lerozot 2.5 Tablet :
Should you forget to take your Lerozot 2.5mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Lerozot 2.5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Diphenylmethane-based compound |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |


